Ovarian Cancer

Ovarian cancer is a heterogeneous group of malignant neoplasms originating from the epithelial, germ, or stromal cells of the ovary. It is characterized by late-stage diagnosis due to vague initial symptoms, often leading to widespread peritoneal dissemination at the time of discovery.

Etiology involves the "ovulatory trauma" theory (repeated rupture of the ovarian epithelium) and hormonal exposure. Genetic factors play a significant role, particularly mutations in BRCA1 and BRCA2 genes, which significantly elevate the risk of hereditary breast and ovarian cancer (HBOC) syndrome.

Most cases (90%) are epithelial in origin (High-Grade Serous Carcinoma). The transformation typically begins in the distal fallopian tube, spreading through the peritoneal fluid to seed the omentum and parietal peritoneum. Metastasis occurs primarily via direct extension into the peritoneal cavity and lymphatic drainage to the pelvic and para-aortic nodes.

Ovarian cancer is the leading cause of death from gynecologic malignancies. It primarily affects postmenopausal women, with a median age of

1. Lifetime risk for the general population is approximately 1.3%.

• Advanced age
• Nulliparity or late parity
• Early menarche/late menopause
• BRCA1/BRCA2 germline mutations
• Lynch syndrome (HNPCC)
• Endometriosis
• Family history of breast/ovarian cancer

A. Early Symptoms: None (mostly asymptomatic).
B. Common Symptoms: Abdominal bloating, pelvic pressure, early satiety, urinary urgency.
C. Advanced Symptoms: Ascites, weight loss, cachexia, bowel obstruction, pleural effusion.
D. Emergency Symptoms: Acute abdominal pain (torsion/rupture), severe bowel obstruction, massive vaginal hemorrhage.

Inspection may reveal abdominal distension or shifting dullness (ascites). Bimanual palpation may reveal a solid, irregular pelvic mass. Auscultation might reveal absent bowel sounds if obstruction is present.

A. Clinical Assessment: Comprehensive pelvic exam and history.
B. Laboratory Testing: CA-125, HE4 levels.
C. Imaging Studies: Transvaginal Ultrasound (TVUS), CT of the abdomen/pelvis.
D. Functional Tests: N/A.
E. Biopsy Findings: Histopathological confirmation (e.g., papillary serous histology).
F. Genetic Testing: BRCA1/2 and HRD testing.
G. Differential Diagnosis: Uterine fibroids, ovarian cysts, diverticulitis, primary peritoneal cancer.

Test Name: CA-125
Type: Blood Test
Purpose: Tumor marker monitoring
Expected Findings: Elevated >35 U/mL
Interpretation: High sensitivity in postmenopausal women for epithelial malignancy.

• Transvaginal Ultrasound: Gold standard for characterizing adnexal masses (size, septation, vascularity).
• CT/PET-CT: Assessment of metastatic burden, nodal involvement, and staging.

Distinguished from benign ovarian cysts by complex morphology (solid components, thick septations) on imaging and rapid doubling of CA-125 levels.

Bowel obstruction, chronic pain, malignant ascites, malnutrition, and venous thromboembolism.

A. Lifestyle Modifications: Smoking cessation, weight management.
B. Preventive Measures: Bilateral salpingo-oophorectomy (BSO) for high-risk individuals.
C. Medical Treatment:

• Platinum-based chemotherapy (Carboplatin, Paclitaxel).


• Targeted therapy (PARP inhibitors: Olaparib, Niraparib).


• Anti-angiogenic (Bevacizumab).

5-year survival rate varies significantly by stage: >90% for stage I, but <30% for stage IV.

Secondary prevention via screening is currently not validated for the general population. Primary prevention includes OCP use and prophylactic surgery.

The following homeopathic remedies have been historically indicated for symptoms associated with Ovarian Cancer. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Ovarian Cancer.